DE60322852D1 - Verfahren zur herstellung von eplerenon - Google Patents

Verfahren zur herstellung von eplerenon

Info

Publication number
DE60322852D1
DE60322852D1 DE60322852T DE60322852T DE60322852D1 DE 60322852 D1 DE60322852 D1 DE 60322852D1 DE 60322852 T DE60322852 T DE 60322852T DE 60322852 T DE60322852 T DE 60322852T DE 60322852 D1 DE60322852 D1 DE 60322852D1
Authority
DE
Germany
Prior art keywords
eplerenone
production
7alpha
processes
pharmaceutical agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322852T
Other languages
English (en)
Inventor
Bruce Allen Pearlman
Amphlett Greg Padilla
Jeffrey L Havens
Sonja S Mackey
Haifeng Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Application granted granted Critical
Publication of DE60322852D1 publication Critical patent/DE60322852D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
DE60322852T 2002-03-22 2003-03-21 Verfahren zur herstellung von eplerenon Expired - Lifetime DE60322852D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36678402P 2002-03-22 2002-03-22
US41187402P 2002-09-19 2002-09-19
US42559602P 2002-11-12 2002-11-12
PCT/US2003/007793 WO2003082895A2 (en) 2002-03-22 2003-03-21 Process to prepare eplerenone

Publications (1)

Publication Number Publication Date
DE60322852D1 true DE60322852D1 (de) 2008-09-25

Family

ID=28678917

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322852T Expired - Lifetime DE60322852D1 (de) 2002-03-22 2003-03-21 Verfahren zur herstellung von eplerenon

Country Status (23)

Country Link
US (2) US20040024202A1 (de)
EP (2) EP1490390A2 (de)
JP (2) JP2005528371A (de)
KR (3) KR20100131018A (de)
CN (2) CN1653081A (de)
AT (1) ATE404577T1 (de)
AU (2) AU2003259022A1 (de)
BR (2) BR0308466A (de)
CA (2) CA2474072A1 (de)
CY (1) CY1108453T1 (de)
DE (1) DE60322852D1 (de)
DK (1) DK1487859T3 (de)
ES (1) ES2310666T3 (de)
HK (1) HK1078588A1 (de)
IL (2) IL164159A0 (de)
MX (2) MXPA04009178A (de)
MY (1) MY138479A (de)
PL (2) PL373189A1 (de)
PT (1) PT1487859E (de)
RS (2) RS90504A (de)
SI (1) SI1487859T1 (de)
TW (2) TW200401781A (de)
WO (2) WO2003082895A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
CL2004000574A1 (es) * 2003-03-21 2005-02-11 Pharmacia Corp Sa Organizada B Proceso para preparar un compuesto 17-espirolactona o la sal de lactona abierta por carbonilacion del correspondiente 17-alquenil o alquinil derivado, los intermediarios que se usan y su proceso de obtencion.
HUP0402466A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
CN1310941C (zh) * 2005-07-13 2007-04-18 南京大学 依普利酮的合成方法
CN1321128C (zh) * 2005-07-15 2007-06-13 浙江医药股份有限公司新昌制药厂 孕甾-4-烯-7,21-二甲酸,9,11-环氧-17-羟基-3-氧代,γ-内酯,甲酯,(7α,11α,17α)-的制备方法
WO2007025780A2 (en) * 2005-09-02 2007-03-08 Recordati Ireland Limited Aldosterone receptor antagonists
JP2007297352A (ja) * 2006-05-02 2007-11-15 Toho Earthtech Inc ヨウ化アルキルの製造方法および2−アルキル置換シクロヘキサノンの製造方法
CN101802207A (zh) * 2007-07-11 2010-08-11 帝斯曼知识产权资产管理有限公司 对映异构选择性还原
WO2009111574A2 (en) * 2008-03-05 2009-09-11 Evestra, Inc. BISMETHYLENE-17α CARBOLACTONES AND RELATED USES
US8222237B2 (en) * 2008-11-25 2012-07-17 Evestra, Inc. Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
CN102464551B (zh) * 2010-11-17 2014-03-26 中国石油化工股份有限公司 异丁烯歧化反应制四甲基乙烯的方法
ES2699923T3 (es) 2014-10-17 2019-02-13 Ind Chimica Srl Proceso para la preparación de 7alfa-(metoxicarbonil)-3-oxo-17alfa-pregn-4,9(11)-dien-21,17-carbolactona, un intermedio útil para la síntesis de moléculas con actividad farmacológica
CN105753930A (zh) * 2016-03-30 2016-07-13 北京万全德众医药生物技术有限公司 依普利酮的一种合成方法
CN108003156B (zh) * 2018-01-29 2021-04-20 辽宁科技大学 一种咪唑并吡啶基1,2-乙二酮衍生物的合成方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US464741A (en) * 1891-12-08 Seed-planter
US3053856A (en) * 1958-10-29 1962-09-11 Shell Oil Co Epoxidation of ethylenic compounds with peroxycarboximidic acids
US3200113A (en) * 1963-01-09 1965-08-10 Sterling Drug Inc 7-cyano steroids and derivatives thereof
US3300489A (en) * 1964-07-24 1967-01-24 Smith Kline French Lab Steroidal c-17 spirolactones and processes and intermediates used in the preparation thereof
US3413288A (en) * 1965-07-07 1968-11-26 Parke Davis & Co Process for the production of steroidal c-17 spirolactones
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
FR2216276B1 (de) * 1973-02-06 1976-11-05 Roussel Uclaf
DE2404948C2 (de) * 1973-02-06 1983-04-14 Roussel-Uclaf, 75007 Paris 7α-Acylthio-Steroidspirolactonderivate
FR2216273B1 (de) * 1973-02-06 1977-07-22 Roussel Uclaf
FR2260569B1 (de) * 1974-02-08 1978-06-16 Ugine Kuhlmann
US3957826A (en) * 1974-03-04 1976-05-18 Hoffmann-La Roche Inc. Spirolactone production
FR2281357A1 (fr) * 1974-08-08 1976-03-05 Roussel Uclaf Nouveau procede de preparation de spirolactones steroides
FR2285137A1 (fr) * 1974-09-18 1976-04-16 Roussel Uclaf Nouveaux derives steroides 17-spirosultines, les g-hydroxyacides correspondants, leur procede de preparation et leur application comme medicament
CH631462A5 (de) * 1976-03-05 1982-08-13 Schering Ag Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe.
US4069219A (en) * 1976-12-27 1978-01-17 G. D. Searle & Co. 7ξ-(Alkoxycarbonyl)-6ξ-alkyl/halo-17-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and corresponding 21-carboxylic acids, their salts, and esters
US4270994A (en) * 1980-02-20 1981-06-02 G. D. Searle & Co. Electrochemical dehydrogenation of steroidal Δ3,5 enol ethers under basic conditions to provide steroidal Δ4,6 dienones
DE3344057A1 (de) * 1982-12-09 1984-06-14 Ciba-Geigy Ag, Basel Eine neue lactonverbindung und pharmazeutische zusammensetzungen davon, sowie verfahren zu ihrer herstellung
JPS59139400A (ja) * 1983-01-31 1984-08-10 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
WO1988002753A2 (en) * 1986-10-10 1988-04-21 Gist-Brocades N.V. 9-alpha-hydroxy steroids and process for their preparation
FR2610933B1 (fr) * 1987-02-18 1989-06-09 Roussel Uclaf Nouveaux 19-nor steroides substitues en position 7, leur preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
DE3903988A1 (de) * 1989-02-10 1990-08-30 Basf Ag Oxidierte diphenylheteroalkane, ihre herstellung und verwendung
US5227375A (en) * 1990-02-08 1993-07-13 Endorecherche, Inc. Aromatase inhibitors
AU680818B2 (en) * 1992-05-21 1997-08-14 Endorecherche Inc. Improved antiandrogens
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
EA009176B1 (ru) * 1995-12-11 2007-12-28 Дж.Д.Серл Энд Ко. Способ получения 7-альфа-карбоксил-9,11-эпоксистероидов и промежуточных продуктов, используемых для их получения, и общий способ эпоксидирования по олефиновым двойным связям
US6887991B1 (en) * 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
RO120710B1 (ro) * 1996-12-11 2006-06-30 G.D.Searle & Co. Procedeu pentru obţinerea 3-ceto-7alfa-alcoxicarbonil-delta4,5-steroizilor şi intermediari pentru obţinerea acestora
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone

Also Published As

Publication number Publication date
CY1108453T1 (el) 2014-04-09
EP1487859A2 (de) 2004-12-22
CN1633445A (zh) 2005-06-29
US20070129332A1 (en) 2007-06-07
WO2003082894A2 (en) 2003-10-09
AU2003259022A1 (en) 2003-10-13
JP2005523306A (ja) 2005-08-04
MXPA04009178A (es) 2004-11-26
WO2003082895A3 (en) 2004-04-22
ATE404577T1 (de) 2008-08-15
WO2003082895A2 (en) 2003-10-09
KR20050028907A (ko) 2005-03-23
EP1487859B1 (de) 2008-08-13
PT1487859E (pt) 2008-10-23
RS83104A (en) 2006-10-27
PL372460A1 (en) 2005-07-25
HK1078588A1 (en) 2006-03-17
ES2310666T3 (es) 2009-01-16
MY138479A (en) 2009-06-30
BR0308660A (pt) 2005-01-25
RS90504A (en) 2006-10-27
US20040024202A1 (en) 2004-02-05
EP1490390A2 (de) 2004-12-29
BR0308466A (pt) 2005-04-26
TW200401781A (en) 2004-02-01
AU2003220251A1 (en) 2003-10-13
TW200404079A (en) 2004-03-16
WO2003082894A3 (en) 2004-04-15
IL164166A0 (en) 2005-12-18
KR20040097201A (ko) 2004-11-17
CA2480151A1 (en) 2003-10-09
CN100473660C (zh) 2009-04-01
JP2005528371A (ja) 2005-09-22
SI1487859T1 (sl) 2008-10-31
CA2474072A1 (en) 2003-10-09
PL373189A1 (en) 2005-08-22
DK1487859T3 (da) 2008-10-06
TWI283245B (en) 2007-07-01
MXPA04009216A (es) 2005-01-25
CN1653081A (zh) 2005-08-10
KR20100131018A (ko) 2010-12-14
IL164159A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
HK1078588A1 (en) Process to prepare eplerenone
ATE276235T1 (de) Verfahren zur herstellung von thiocarbonsäuren
DE602005023877D1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ECSP055584A (es) Proceso para la preparación de fibrinógeno
DE60202958D1 (de) Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten
DE602006019870D1 (de) Verfahren zur synthese von triazolen
DE602005021395D1 (de) GROßTECHNISCHES VERFAHREN ZUR HERSTELLUNG VON 17-HYDROXY-6BETA, 7BETA, 15BETA,16BETA-BISMETHYLEN-3-OXO-17ALPHA-PREGN-4-EN-21-CARBONSÄURE-GAMMA-LACTON UND SCHLÜSSELZWISCHENPRODUKTE FÜR DIESES VERFAHREN
ATE461934T1 (de) Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-car onsäure -lacton und schlüsselzwischenprodukte für dieses verfahren
DE60311990D1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
DE50312796D1 (de) Verfahren zur herstellung von isocyanaten
ATE378309T1 (de) Verfahren zur reinigung und herstellung von fluorkohlenwasserstoffen
ATE270275T1 (de) Verfahren zur herstellung von 2-aryl-3-aryl-5- halogen-pyridinen, verwendbar als cox-2 inhibitoren
ATE337796T1 (de) Verfahren zur herstellung von hyperpolarisiertem 129xe
DE60308388D1 (de) 5-androsten-3-olsteroidzwischenprodukte und verfahren zu deren herstellung
ATE377020T1 (de) Kristallines gamma-lacton der17beta-hydroxy-
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE60318444D1 (de) Verfahren zur herstellung von nevirapin
DE602004031727D1 (de) Neues verfahren und zwischenprodukte zur herstellung von 19-nor-steroiden
ATE406376T1 (de) Verfahren zur herstellung von finasterid form i
DE602006008751D1 (de) Synthese von proteaseinhibitorvorstufen
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
DE502006005580D1 (de) Verfahren zur herstellung von optisch aktiven 3-phenylpropionsäurederivaten und folgeprodukte davon
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
DE50206615D1 (de) Verfahren zur Herstellung von 15-Pentadecanolid
ATE411999T1 (de) Verfahren und zwischenprodukte für die herstellung von olanzapin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition